Cash Flow Statement
Growth Metrics

Sintx Technologies (SINT) Current Leases (2016 - 2026)

Sintx Technologies' quarterly Current Leases came in at $422000.0 in Q1 2026, up 17.55% year-on-year from $359000.0 in Q1 2025, and up 6.03% quarter-over-quarter from $398000.0 in Q4 2025.

Sintx Technologies has reported Current Leases for 10 years, with the latest figure at $422000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 17.55% year-over-year to $422000.0; the trailing twelve-month figure through Mar 2026 stood at $422000.0 (up 17.55% YoY), and the FY2025 full-year result was $398000.0, down 12.72% from the prior year.
  • Current Leases for Q1 2026 stood at $422000.0, up from $398000.0 in the prior quarter.
  • The five-year high for Current Leases was $797000.0 in Q3 2023, with the low at $359000.0 in Q1 2025.
  • Average Current Leases over 5 years is $551470.6, with a median of $512000.0 recorded in 2023.
  • Year-over-year, Current Leases jumped 66.67% in 2022 and tumbled 41.15% in 2024.
  • Tracing SINT's Current Leases over 5 years: stood at $738000.0 in 2022, then plunged by 30.62% to $512000.0 in 2023, then fell by 10.94% to $456000.0 in 2024, then decreased by 12.72% to $398000.0 in 2025, then rose by 6.03% to $422000.0 in 2026.
  • The last three Current Leases figures came in at $422000.0 (Q1 2026), $398000.0 (Q4 2025), and $384000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Sintx Technologies 8.71 Mn 6.82 Mn 144,000.00 422,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 422,000.00
Dec 31, 2025 398,000.00
Sep 30, 2025 384,000.00
Jun 30, 2025 371,000.00
Mar 31, 2025 359,000.00
Dec 31, 2024 456,000.00
Sep 30, 2024 469,000.00
Jun 30, 2024 494,000.00
Mar 31, 2024 518,000.00
Dec 31, 2023 512,000.00
Sep 30, 2023 797,000.00
Jun 30, 2023 769,000.00
Mar 31, 2023 750,000.00
Dec 31, 2022 738,000.00
Sep 30, 2022 720,000.00
Jun 30, 2022 705,000.00
Mar 31, 2022 513,000.00
Dec 31, 2021 500,000.00
Sep 30, 2021 478,000.00
Jun 30, 2021 423,000.00
Mar 31, 2021 413,000.00
Dec 31, 2020 403,000.00
Sep 30, 2020 393,000.00
Jun 30, 2020 383,000.00
Mar 31, 2020 372,000.00
Dec 31, 2019 360,000.00
Sep 30, 2019 475,000.00
Jun 30, 2019 587,000.00
Mar 31, 2019 715,000.00
Dec 31, 2018 169,000.00
Sep 30, 2016 19,000.00
Jun 30, 2016 19,000.00